[HTML][HTML] Renal dysfunction in cardiovascular diseases and its consequences

G Deferrari, A Cipriani, E La Porta - Journal of nephrology, 2021 - Springer
It is well known that the heart and kidney and their synergy is essential for hemodynamic
homeostasis. Since the early XIX century it has been recognized that cardiovascular and …

[HTML][HTML] Stable gastric pentadecapeptide BPC 157 as useful cytoprotective peptide therapy in the heart disturbances, myocardial infarction, heart failure, pulmonary …

P Sikiric, M Udovicic, I Barisic, D Balenovic… - Biomedicines, 2022 - mdpi.com
In heart disturbances, stable gastric pentadecapeptide BPC 157 especial therapy effects
combine the therapy of myocardial infarction, heart failure, pulmonary hypertension …

[HTML][HTML] Ferric carboxymaltose in iron-deficient patients with hospitalized heart failure and reduced kidney function

IC Macdougall, P Ponikowski, AG Stack… - Clinical Journal of the …, 2023 - journals.lww.com
Background Reduced kidney function is common among patients with heart failure. In
patients with heart failure and/or kidney disease, iron deficiency is an independent predictor …

[HTML][HTML] Economic modelling of chronic kidney disease: a systematic literature review to inform conceptual model design

DM Sugrue, T Ward, S Rai, P McEwan… - …, 2019 - Springer
Background Chronic kidney disease (CKD) is a progressive condition that leads to
irreversible damage to the kidneys and is associated with an increased incidence of …

The influence of heart failure on the pharmacokinetics of cardiovascular and non‐cardiovascular drugs: a critical appraisal of the evidence

AA Mangoni, EA Jarmuzewska - British Journal of Clinical …, 2019 - Wiley Online Library
Prescribing in heart failure (HF), a common disease state that predominantly affects the
older population, is often a challenging task because of the dynamic nature of the condition …

Proteomic biomarkers in the cardiorenal syndrome: Toward deciphering molecular pathophysiology

T He, Z Zhang, JA Staessen, H Mischak… - American journal of …, 2021 - academic.oup.com
Cardiorenal syndrome (CRS) is defined by coexisting heart and renal dysfunctions.
Malfunction of 1 organ may cause dysfunction of the other with variable causative disease …

Association between the lipid profile and renal dysfunction in the heart failure patients

H Zhang, S Shi, XJ Zhao, JK Wang, ZW Liu… - Kidney and Blood …, 2019 - karger.com
Abstract Background/Aims: In heart failure patients with high prevalence of chronic renal
disease (CKD), hospitalization and mortality, whether the lipid profile was associated with …

Poor prognosis of heart failure patients with in‐hospital worsening renal function and elevated BNP at discharge

T Okabe, T Yakushiji, T Kido, T Kimura… - ESC Heart …, 2020 - Wiley Online Library
Aims Our purpose was to investigate the association between the B‐type natriuretic peptide
(BNP) level at discharge, the occurrence of worsening renal function (WRF), and long‐term …

[HTML][HTML] Cystatin C-based CKD-EPI estimated glomerular filtration rate equations as a better strategy for mortality stratification in acute heart failure: a STROBE …

I Cheang, S Liao, W Yao, X Lu, R Gao, Y Zhou… - Medicine, 2020 - journals.lww.com
Cystatin C-based CKD-EPI estimated glomerular filtration rat... : Medicine Cystatin C-based
CKD-EPI estimated glomerular filtration rate equations as a better strategy for mortality …

Characteristics and outcome of hospitalized patients with heart failure stratified for chronic kidney disease

S König, V Pellissier, S Hohenstein, J Leiner… - ESC Heart …, 2024 - Wiley Online Library
Aims Heart failure (HF) and chronic kidney disease (CKD) place significant challenges on
the healthcare system, and their co‐existence is associated with shared adverse outcomes …